Purity testing is the entire basis on which a research peptide can be trusted, and the certificate reporting it is usually read as a single number. That number is the least informative part of the document.
This guide covers how peptide purity is actually measured, what HPLC and mass spectrometry each answer, why both are necessary, what the impure fraction consists of, how to read a purity figure in context, and what separates a meaningful certificate from a decorative one. Everything here describes laboratory analysis of research materials, not personal use.
What peptide purity testing measures
Two separate questions have to be answered about any vial, and they require different methods.
Identity. Is this the compound it claims to be? Answered by mass spectrometry, comparing measured molecular mass against the expected mass for the specified sequence.
Purity. What proportion of the material is that compound? Answered by chromatography, typically HPLC, separating the sample into components and measuring their relative proportions.
Neither alone is sufficient, and publishing only one is the most common half-measure in this market. HPLC on the wrong compound reports excellent purity for the wrong thing. Mass spectrometry on a contaminated sample confirms the target is present without saying how much of the vial is something else.
The batch certificate of analysis lays out reading the document these produce.
How HPLC works
High performance liquid chromatography is the workhorse of peptide purity analysis, and the principle is more intuitive than the name suggests.
The sample is dissolved and pushed under pressure through a column packed with material that interacts with molecules according to their properties. Different components travel through at different rates depending on how strongly they interact with the packing.
A detector at the far end records what emerges and when, producing a trace with peaks. Each peak represents a component, and the area under a peak is proportional to how much of that component was present.
Purity is calculated from the relative peak areas: the target compound’s peak as a proportion of the total. A 98 percent figure means the target peak accounts for 98 percent of the total detected area.
What HPLC does not tell you is what any peak actually is. It separates and quantifies without identifying, which is precisely why the second method is required.
How mass spectrometry works
The identity half of the answer, using a completely different principle.
The sample is ionised and the resulting ions are separated according to their mass-to-charge ratio, producing a spectrum showing which masses are present.
Because every peptide sequence has a calculable molecular mass determined by its constituent amino acids, the measured mass can be compared against the expected value. A match confirms the sequence is consistent with what was specified.
This is genuinely powerful. A peptide missing a single amino acid has a different mass, and mass spectrometry detects that difference readily.
Its limit is that it confirms presence rather than proportion. Detecting the correct mass establishes the target is in the vial. It does not establish that the vial is mostly that compound, which is what the chromatography contributes.
What the impure fraction actually consists of
Understanding this makes purity figures far more legible, and it is reassuring in a way most people do not expect.
Peptides are built by solid phase synthesis, adding amino acids one at a time to a chain anchored on a support. Each coupling step runs at high efficiency, and high is not perfect.
Across fifteen or thirty steps, those small failures accumulate into a population of truncated sequences: chains missing a residue, or two, or terminating early. They are chemically very similar to the target, which is exactly what makes separating them difficult.
Purification removes most of them. What remains after purification, alongside residual reagents and solvents from the process, is the impurity fraction the purity figure quantifies.
So a 98 percent figure is not 2 percent unknown contamination. It is largely closely related sequences that survived separation, which is a different and less alarming proposition than the number suggests in isolation. Research grade peptides covers the manufacturing side.
Why sequence length changes what a figure means
The same percentage represents very different manufacturing achievements depending on the molecule.
A tripeptide like KPV or GHK-Cu has few coupling steps and correspondingly few opportunities for truncation. High purity is comparatively straightforward.
A longer sequence has many more steps, each contributing its small failure rate, and the accumulated population of related impurities is larger and harder to separate. The same 98 percent on a thirty-residue sequence is a harder-won number.
The practical consequence is that comparing purity figures across different compounds tells you very little. Comparing them across suppliers for the same compound is more meaningful, provided the methods and documentation are comparable.
What makes a purity figure meaningful
Three things beyond the number itself, none of which are visible in the percentage.
The method. HPLC conditions affect what the analysis resolves. A figure with no stated method has no basis for comparison against another figure.
The laboratory. Independent third-party testing is a different proposition from in-house analysis. In-house is not worthless and it is a manufacturer assessing its own output.
The batch. A figure tied to a lot number matching your vial describes your material. A generic figure describes a batch somewhere, once.
A batch-specific figure from a named independent laboratory with a stated method beats a higher number lacking those attributes, consistently. The peptide supplier checklist walks through demanding them.
What purity testing does not establish
Worth stating clearly, because purity gets treated as a proxy for things it says nothing about.
It says nothing about safety. Verified identity and purity describe what is in the vial, not how the compound behaves in a living system. The peptide safety evidence sets out why that is a separate evidence base entirely.
It says nothing about efficacy or about how well studied a compound is. A barely researched compound can be manufactured to an impeccable analytical standard, and a well studied one can be supplied as poor material.
And it says nothing about how the vial has been handled since testing. Storage degradation is invisible and occurs after the certificate was issued. Peptide storage conditions cover that gap.
Reading an HPLC trace, in outline
Some certificates include the actual chromatogram rather than only the summary figure, and knowing roughly how to read one is useful even without formal training.
The trace is a line moving across time on the horizontal axis, with detector signal on the vertical axis. A pure, well-resolved sample shows one large, sharp, symmetric peak corresponding to the target compound, standing well clear of the baseline.
Smaller peaks elsewhere on the trace represent the impurity fraction discussed above: truncated sequences and related synthesis byproducts. Their number and size give a visual sense of how clean the separation was, beyond the single percentage figure calculated from them.
A trace showing a broad, poorly defined main peak, or one crowded closely by several similarly sized neighbouring peaks, indicates a less clean separation even if the calculated percentage looks acceptable, because peak overlap can distort the area calculation. A supplier willing to include the actual trace rather than only the number is giving you more to evaluate, which is itself informative about how much confidence they have in the result.
Why testing has to happen after synthesis, not instead of process control
Worth understanding the relationship between manufacturing and testing, since they are sometimes presented as substitutes for each other and they are not.
Careful process control during synthesis, meaning well-optimised coupling steps and appropriate reagents, reduces how much impure material forms in the first place. That is a manufacturing quality question, addressed before the fact.
Testing happens after synthesis is complete, on the finished material, and it can only report what is actually present. It cannot compensate for poor process control, and good process control does not eliminate the need for it, because even well-optimised synthesis produces some impure fraction.
A batch certificate is therefore not a substitute for asking about manufacturing standards generally. It is the specific, checkable evidence for one batch, and it is the part a buyer can actually verify without touring a facility. Choosing a peptide supplier explains the manufacturing-adjacent questions worth asking alongside it.
Additional tests that sometimes appear
Beyond the two core methods, some certificates report further analysis.
Water content matters because lyophilized material retains some residual moisture, which affects the actual peptide mass relative to the nominal fill. The freeze-drying process is why.
Peptide content or assay reports the proportion of the total vial mass that is peptide as opposed to counterions, water and excipients. This is a distinct figure from chromatographic purity and is frequently confused with it.
Endotoxin and sterility testing appear in some documentation, addressing microbial contamination rather than chemical composition.
More tests is generally better, and their absence is not automatically a failure. Identity and purity are the load-bearing pair.
Peptide purity testing: frequently asked questions
How is peptide purity tested?
By HPLC, which separates the sample into components and measures their relative proportions, giving the purity percentage. Identity is confirmed separately by mass spectrometry, comparing measured molecular mass against the expected value.
Why are two different tests needed?
HPLC quantifies without identifying, and mass spectrometry identifies without quantifying. Purity analysis on the wrong compound reports a high figure for the wrong thing, and mass spec alone cannot say how much of the vial is something else.
What is in the impure fraction?
Mostly closely related sequences from synthesis, such as chains missing a residue or terminating early, plus residual reagents and solvents. A 98 percent figure is not 2 percent unknown contamination.
What purity should a research peptide be?
Around 98 percent and above is the general expectation, though the figure means different things for different sequence lengths. Comparing across compounds tells you little; comparing across suppliers for the same compound is more meaningful.
Does higher purity mean better quality?
Not comparably. A batch-specific figure from a named independent laboratory with a stated method is worth more than a higher number lacking those attributes, because provenance is the substance of the claim.
Does purity testing prove a compound is safe?
No. It describes what is in the vial, not how the compound behaves in a living system. Safety is a separate question answered by a separate evidence base, which is what peptide safety evidence addresses.
What is peptide content and how is it different?
Peptide content reports what proportion of the total vial mass is peptide rather than counterions, water and excipients. It is a distinct figure from chromatographic purity and the two are frequently confused.
Does a certificate cover the vial I received?
Only if it carries a lot number matching your vial. A generic certificate describes some batch, once, and says nothing about the specific material you are holding.
Compounds discussed above, each shipped with a published batch certificate: BPC-157. Everything else in this area sits in the full catalogue.
Can purity be checked after a vial arrives?
Not without sending it to a laboratory, which costs more than most vials. That asymmetry is the whole reason the certificate matters: it is the only practical evidence a buyer has, so a vendor unwilling to publish one before purchase is asking for trust it has not earned.
Does higher purity mean a better compound?
It means less of something else. What that something else is matters more than the percentage, because truncated sequences and synthesis byproducts are not inert filler, and a certificate that states purity without confirming identity has told you only half the story.
The number is the least of it
Purity testing is the only mechanism by which a white powder becomes a known quantity, and the headline percentage is the part that carries the least information. Method, laboratory and lot number are what make the figure mean anything, and they are all checkable before purchase. Every batch across the weight loss collection and skin and beauty collection is documented in third-party lab results.
Related reading
- How to Read a Certificate of Analysis, the document field by field.
- What Research Grade Peptides Means, what the testing certifies.
- How to Choose a Peptide Supplier, demanding the documentation.
- Peptide Calculator, for reconstitution and concentration math.